Q: Is 360 High-Risk Vulnerability Immunization Tool V2.0 a good alternative to Siemba GenVA?

360 High-Risk Vulnerability Immunization Tool V2.0 and Siemba GenVA serve similar Vulnerability Assessment use cases: both are Vulnerability Assessment tools. Review the feature comparison above to determine which fits your requirements.

Question 1

What is the difference between 360 High-Risk Vulnerability Immunization Tool V2.0 vs Siemba GenVA?

Accepted Answer

**360 High-Risk Vulnerability Immunization Tool V2.0**: Tool that immunizes Windows systems against critical vulnerabilities. built by 360 Security Group (Qihoo 360). headquartered in China. Core capabilities include Remote desktop vulnerability immunization (CVE-2019-0708, CVE-2019-1181, CVE-2019-1182), MS17-010 SMB vulnerability protection against ransomware, Meltdown CPU vulnerability mitigation..

**Siemba GenVA**: AI-powered vulnerability assessment engine for threat prioritization. built by Siemba. headquartered in United States. Core capabilities include AI-driven threat correlation mapping vulnerabilities to exploits and malware, Continuous vulnerability scanning with TCP/UDP and ICMP discovery, Automated finding grouping by severity, status, and confidence..

Both serve the Vulnerability Assessment market but differ in approach, feature depth, and target audience.

Question 2

What features do 360 High-Risk Vulnerability Immunization Tool V2.0 vs Siemba GenVA offer?

Accepted Answer

**360 High-Risk Vulnerability Immunization Tool V2.0** differentiates with Remote desktop vulnerability immunization (CVE-2019-0708, CVE-2019-1181, CVE-2019-1182), MS17-010 SMB vulnerability protection against ransomware, Meltdown CPU vulnerability mitigation. **Siemba GenVA** differentiates with AI-driven threat correlation mapping vulnerabilities to exploits and malware, Continuous vulnerability scanning with TCP/UDP and ICMP discovery, Automated finding grouping by severity, status, and confidence.

Question 3

Who makes 360 High-Risk Vulnerability Immunization Tool V2.0 vs Siemba GenVA?

Accepted Answer

**360 High-Risk Vulnerability Immunization Tool V2.0** is developed by 360 Security Group (Qihoo 360). **Siemba GenVA** is developed by Siemba. Vendor maturity, funding stage, and team size can be important factors when evaluating long-term viability and support quality.